Halit Eren Taskin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Halit Eren Taskin has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
Muzaffer Al
Department of Surgery, Faculty of Medicine, Near East University Nicosia, Turkey
6 shared publications- Volkan Yumuk
Division of Endocrinology, Metabolism and Diabetes, Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, Istanbul, Turkey
4 shared publications - Chetan Parmar
Whittington Hospital, London, UK
2 shared publications - Christine Stier
Department of Surgery, Division of Bariatric Endoscopy Heidelberg University Mannheim Germany
2 shared publications - Dilek Yazici
Department of Endocrinology and Metabolism, Koc University Faculty of Medicine, Istanbul, Turkey
2 shared publications Feray Akbas
2 shared publications
Latest Publications
- 11 November 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-13
Comparative Mid-Term Outcomes of Omega Gastric Bypass Versus SASI Bypass: A Retrospective Cohort Study
- 11 November 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-13
Comparative Mid-Term Outcomes of Omega Gastric Bypass Versus SASI Bypass: A Retrospective Cohort Study
- 6 November 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-13
Total Small Bowel Length and Limb-length Decision-making in Metabolic and Bariatric Surgery for Asian Populations: An APMBSS 2026 Modified Delphi Expert Consensus Statement
Introduction Total small bowel length (TSBL) varies substantially and may modify the physiological effect of intestinal bypass in metabolic and bariatric surgery (MBS). Fixed limb lengths do not account for individual variation and may contribute to suboptimal metabolic effect or excessive malabsorption. Methods The APMBSS 2026 TSBL Consensus Panel used a two-round modified Delphi process. Faculty rated 38 statements across seven domains on a 5-point Likert scale. Thirty-five statements reached consensus in Round 1 and were reaffirmed during faculty review at the congress without repeat scoring; only three were revised and revoted. Consensus required a median score of at least 4 and at least 80% of ratings at 4 or 5; strong consensus required at least 90% agreement. Results Forty-one analyzable responses from 15 countries/regions were included in Round 1. Thirty-five statements reached consensus. Three statements were discussed, revised, and revoted; one additional statement reached consensus. Overall, 36 of 38 statements achieved consensus (30 strong, 6 consensus). No final consensus was reached on routine TSBL measurement during standard sleeve gastrectomy or on diminishing metabolic returns beyond a 150-cm biliopancreatic limb in Roux-en-Y gastric bypass. Conclusion The consensus supports standardized measurement and documentation of TSBL and procedure-specific limb lengths in bypass-based procedures. It does not prescribe a universal limb-length formula, but establishes a framework for interpreting bypass physiology, balancing metabolic efficacy and nutritional safety, and evaluating TSBL-adjusted strategies in Asian registries and prospective studies. Key Points • TSBL provides an anatomical denominator for interpreting intestinal bypass. • Standardized TSBL and limb-length documentation was supported by the panel. • No universal TSBL-adjusted limb-length formula was supported. • The panel supported a minimum 300-cm common channel for SADI-S in Asian populations.
- 6 November 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-13
Total Small Bowel Length and Limb-length Decision-making in Metabolic and Bariatric Surgery for Asian Populations: An APMBSS 2026 Modified Delphi Expert Consensus Statement
Introduction Total small bowel length (TSBL) varies substantially and may modify the physiological effect of intestinal bypass in metabolic and bariatric surgery (MBS). Fixed limb lengths do not account for individual variation and may contribute to suboptimal metabolic effect or excessive malabsorption. Methods The APMBSS 2026 TSBL Consensus Panel used a two-round modified Delphi process. Faculty rated 38 statements across seven domains on a 5-point Likert scale. Thirty-five statements reached consensus in Round 1 and were reaffirmed during faculty review at the congress without repeat scoring; only three were revised and revoted. Consensus required a median score of at least 4 and at least 80% of ratings at 4 or 5; strong consensus required at least 90% agreement. Results Forty-one analyzable responses from 15 countries/regions were included in Round 1. Thirty-five statements reached consensus. Three statements were discussed, revised, and revoted; one additional statement reached consensus. Overall, 36 of 38 statements achieved consensus (30 strong, 6 consensus). No final consensus was reached on routine TSBL measurement during standard sleeve gastrectomy or on diminishing metabolic returns beyond a 150-cm biliopancreatic limb in Roux-en-Y gastric bypass. Conclusion The consensus supports standardized measurement and documentation of TSBL and procedure-specific limb lengths in bypass-based procedures. It does not prescribe a universal limb-length formula, but establishes a framework for interpreting bypass physiology, balancing metabolic efficacy and nutritional safety, and evaluating TSBL-adjusted strategies in Asian registries and prospective studies. Key Points • TSBL provides an anatomical denominator for interpreting intestinal bypass. • Standardized TSBL and limb-length documentation was supported by the panel. • No universal TSBL-adjusted limb-length formula was supported. • The panel supported a minimum 300-cm common channel for SADI-S in Asian populations.
- Open Access
- 23 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (7) , 1-11
Reliability of the Overnight Dexamethasone Suppression Test in Patients Undergoing Bariatric Surgery
Introduction: Bariatric surgery is the most effective treatment for severe cases in obesity. However, the altered gastrointestinal anatomy after bariatric surgery can affect drug absorption, potentially leading to false-positive results in diagnostic tests. This study aims to evaluate the reliability of dexamethasone suppression test (DST) in post-bariatric surgery patients and explore how different bariatric procedures influence DST outcomes. Methods: In this single-center, cross-sectional study conducted at the Obesity Center in tertiary university hospital. Patients who had undergone bariatric surgery, completed at least 9–12 months of postoperative recovery, and had a pre-operative DST were included the study. Sociodemographic and clinical data were obtained. All patients underwent an overnight DST and laboratory tests. Results: Sixty-eight patients included study: 47 sleeve gastrectomy (SG), 21 Roux-en-Y gastric bypass (RYGB). Baseline weight and BMI were similar ( p = 0.68, p = 0.873, respectively). At last follow-up, RYGB patients had lower weight compared to SG ( p = 0.049). Postoperative DST levels showed no significant change in SG ( p = 0.055), but increased significantly in RYGB (0.72 vs. 0.84; p = 0.028). Although postoperative DST values were higher in RYGB, the difference between groups was not significant ( p = 0.196). A moderate positive correlation was found between pre- and postoperative DST values ( r = 0.464, p < 0.001), with no association between DST and sex, surgery type, BMI, or weight loss. Conclusions: Despite potential alterations in absorption after bariatric surgery, the DST appeared to remain reliable and adequately suppressed cortisol in the majority of patients. Thus, our findings suggest that DST may be considered a safe and valid screening tool for Cushing’s syndrome in patients undergoing bariatric surgery.
- 23 May 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (7) , 1-11
Open AccessReliability of the Overnight Dexamethasone Suppression Test in Patients Undergoing Bariatric Surgery
Introduction: Bariatric surgery is the most effective treatment for severe cases in obesity. However, the altered gastrointestinal anatomy after bariatric surgery can affect drug absorption, potentially leading to false-positive results in diagnostic tests. This study aims to evaluate the reliability of dexamethasone suppression test (DST) in post-bariatric surgery patients and explore how different bariatric procedures influence DST outcomes. Methods: In this single-center, cross-sectional study conducted at the Obesity Center in tertiary university hospital. Patients who had undergone bariatric surgery, completed at least 9–12 months of postoperative recovery, and had a pre-operative DST were included the study. Sociodemographic and clinical data were obtained. All patients underwent an overnight DST and laboratory tests. Results: Sixty-eight patients included study: 47 sleeve gastrectomy (SG), 21 Roux-en-Y gastric bypass (RYGB). Baseline weight and BMI were similar ( p = 0.68, p = 0.873, respectively). At last follow-up, RYGB patients had lower weight compared to SG ( p = 0.049). Postoperative DST levels showed no significant change in SG ( p = 0.055), but increased significantly in RYGB (0.72 vs. 0.84; p = 0.028). Although postoperative DST values were higher in RYGB, the difference between groups was not significant ( p = 0.196). A moderate positive correlation was found between pre- and postoperative DST values ( r = 0.464, p < 0.001), with no association between DST and sex, surgery type, BMI, or weight loss. Conclusions: Despite potential alterations in absorption after bariatric surgery, the DST appeared to remain reliable and adequately suppressed cortisol in the majority of patients. Thus, our findings suggest that DST may be considered a safe and valid screening tool for Cushing’s syndrome in patients undergoing bariatric surgery.
- 2 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 628-638
Comparison of Early Results of Aesthetic Focused Bikini-Line Sleeve Gastrectomy and Standard Laparoscopic Sleeve Gastrectomy
Background The Bikini-line sleeve gastrectomy is a modification of standard laparoscopic sleeve gastrectomy designed primarily to improve aesthetic outcomes by relocating trocars to the lower abdomen. It offers aesthetic advantages without additional metabolic or functional benefit. Purpose The study compared early clinical outcomes, pain, scar satisfaction, and post-operative pain between Bikini-line sleeve gastrectomy and standard laparoscopic sleeve gastrectomy. Materials and methods This retrospective cohort study of 364 patients: 216 in laparoscopic sleeve gastrectomy and 148 in bikini line sleeve gastrectomy operated from January 2023 to December 2023. Demographics, operating time, length of hospital stay, excess weight loss, pain scores, scar satisfaction, and complications have been assessed. Patients with BMI ≥ 30 kg/m² with T2DM, BMI 35–39.9 kg/m² with comorbidities, and BMI ≥ 40 kg/m² were included. However, patients with a progressive history of a major open abdominal surgery, persistent hiatal hernia of more than 4 cm, and patients who refused to use the bikini-line method were excluded. The study applied the Kolmogorov-Smirnov test to ascertain the normality of the data. Student’s t-test was used for normally distributed variables, and the Mann–Whitney U test for non-normally distributed ones. Chi-square and Fisher exact tests ensured stable examination of operative time, pain, scar satisfaction, EWL, and complications. Results The laparoscopic sleeve gastrectomy group had a higher preoperative BMI (42.49 ± 6.19 vs. 38.52 ± 4.72, p < 0.001). No significant differences were observed in excess weight loss % at 3, 6, and 12 months between laparoscopic sleeve gastrectomy and bikini-line sleeve gastrectomy (35.8% vs. 35.9%, p = 0.667; 49.6% vs. 49.2%, p = 0.356; 56.0% vs. 56.3%, p = 0.390). Postoperative 12 h pain was significantly lower in the bikini line sleeve gastrectomy group (4.14 ± 0.78 vs. 5.35 ± 1.02, p < 0.001), while scar satisfaction scores at discharge and at 12 months were markedly higher (p < 0.001). Complication rates (bleeding p = 0.149; thromboembolism p = 1.000; infection p = 0.125) and operation times (p = 0.131) were similar between groups. Conclusion Bikini-line sleeve gastrectomy demonstrated comparable weight loss and complication rates to standard laparoscopic sleeve gastrectomy, while significantly reducing early postoperative pain and improving scar satisfaction. Although feasible and safe in selected patients with appropriate closure, Bikini-line sleeve gastrectomy is primarily an aesthetic adaptation rather than a replacement for standard laparoscopic sleeve gastrectomy.
- 2 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 628-638
Comparison of Early Results of Aesthetic Focused Bikini-Line Sleeve Gastrectomy and Standard Laparoscopic Sleeve Gastrectomy
Background The Bikini-line sleeve gastrectomy is a modification of standard laparoscopic sleeve gastrectomy designed primarily to improve aesthetic outcomes by relocating trocars to the lower abdomen. It offers aesthetic advantages without additional metabolic or functional benefit. Purpose The study compared early clinical outcomes, pain, scar satisfaction, and post-operative pain between Bikini-line sleeve gastrectomy and standard laparoscopic sleeve gastrectomy. Materials and methods This retrospective cohort study of 364 patients: 216 in laparoscopic sleeve gastrectomy and 148 in bikini line sleeve gastrectomy operated from January 2023 to December 2023. Demographics, operating time, length of hospital stay, excess weight loss, pain scores, scar satisfaction, and complications have been assessed. Patients with BMI ≥ 30 kg/m² with T2DM, BMI 35–39.9 kg/m² with comorbidities, and BMI ≥ 40 kg/m² were included. However, patients with a progressive history of a major open abdominal surgery, persistent hiatal hernia of more than 4 cm, and patients who refused to use the bikini-line method were excluded. The study applied the Kolmogorov-Smirnov test to ascertain the normality of the data. Student’s t-test was used for normally distributed variables, and the Mann–Whitney U test for non-normally distributed ones. Chi-square and Fisher exact tests ensured stable examination of operative time, pain, scar satisfaction, EWL, and complications. Results The laparoscopic sleeve gastrectomy group had a higher preoperative BMI (42.49 ± 6.19 vs. 38.52 ± 4.72, p < 0.001). No significant differences were observed in excess weight loss % at 3, 6, and 12 months between laparoscopic sleeve gastrectomy and bikini-line sleeve gastrectomy (35.8% vs. 35.9%, p = 0.667; 49.6% vs. 49.2%, p = 0.356; 56.0% vs. 56.3%, p = 0.390). Postoperative 12 h pain was significantly lower in the bikini line sleeve gastrectomy group (4.14 ± 0.78 vs. 5.35 ± 1.02, p < 0.001), while scar satisfaction scores at discharge and at 12 months were markedly higher (p < 0.001). Complication rates (bleeding p = 0.149; thromboembolism p = 1.000; infection p = 0.125) and operation times (p = 0.131) were similar between groups. Conclusion Bikini-line sleeve gastrectomy demonstrated comparable weight loss and complication rates to standard laparoscopic sleeve gastrectomy, while significantly reducing early postoperative pain and improving scar satisfaction. Although feasible and safe in selected patients with appropriate closure, Bikini-line sleeve gastrectomy is primarily an aesthetic adaptation rather than a replacement for standard laparoscopic sleeve gastrectomy.
- Open Access
- 27 November 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e950798
Gastric Bipartition with Functional Duodenum Exclusion (GBp-FDE) as a Possible Surgical Conversion of Sleeve Gastrectomy in Patients with De Novo GERD and Obesity Recidivism: Preliminary Results of a Case Series
BACKGROUND Sleeve gastrectomy (SG) is widely used in obesity treatment, although it is associated with new onset of gastroesophageal reflux disease (de novo GERD) and weight regain. Roux-en-Y gastric bypass (RYGB) is the standard revisional procedure for GERD, though it offers limited additional weight loss. Ileal-based procedures have demonstrated superior outcomes regarding weight loss but have uncertain results in GERD. This study presents preliminary findings on gastric bipartition with functional duodenal exclusion (GBp-FDE) as a revisional approach following SG in this scenario. CASE REPORT A retrospective data analysis was conducted on 10 patients who underwent GBp-FDE due to de novo GERD and obesity recurrence after SG (mean BMI: 37.2±3.2 kg/m²). Nine patients presented with hiatal hernia and 8 with sleeve dilation. GERD was assessed pre- and postoperatively using a validated questionnaire, endoscopy, and contrast radiology. The surgical technique involved a pre-pyloric antroileostomy in Roux-en-Y configuration using a 40% proportion biliopancreatic limb. One-year postoperative findings included pyloric spasm (endoscopy), very preferential contrast flow to the ileum (radiology), and endoscopic access preservation to the duodenum. GERD symptoms resolved in 90% (P=0.0059) and esophagitis healed in 80% (P=0.008), likely due to gastric decompression. Mean percent total weight loss and percent excess weight loss were 35.2±6.6 and 108.0±11.14, respectively. CONCLUSIONS GBp-FDE seems to be a promising surgery for managing de novo GERD and obesity recurrence after SG, through SG pouch decompression and ileal stimuli, promoted by the antroileostomy. Further controlled studies with extended follow-up are necessary to validate these findings.
- 27 November 2025
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 26, e950798
Open AccessGastric Bipartition with Functional Duodenum Exclusion (GBp-FDE) as a Possible Surgical Conversion of Sleeve Gastrectomy in Patients with De Novo GERD and Obesity Recidivism: Preliminary Results of a Case Series
BACKGROUND Sleeve gastrectomy (SG) is widely used in obesity treatment, although it is associated with new onset of gastroesophageal reflux disease (de novo GERD) and weight regain. Roux-en-Y gastric bypass (RYGB) is the standard revisional procedure for GERD, though it offers limited additional weight loss. Ileal-based procedures have demonstrated superior outcomes regarding weight loss but have uncertain results in GERD. This study presents preliminary findings on gastric bipartition with functional duodenal exclusion (GBp-FDE) as a revisional approach following SG in this scenario. CASE REPORT A retrospective data analysis was conducted on 10 patients who underwent GBp-FDE due to de novo GERD and obesity recurrence after SG (mean BMI: 37.2±3.2 kg/m²). Nine patients presented with hiatal hernia and 8 with sleeve dilation. GERD was assessed pre- and postoperatively using a validated questionnaire, endoscopy, and contrast radiology. The surgical technique involved a pre-pyloric antroileostomy in Roux-en-Y configuration using a 40% proportion biliopancreatic limb. One-year postoperative findings included pyloric spasm (endoscopy), very preferential contrast flow to the ileum (radiology), and endoscopic access preservation to the duodenum. GERD symptoms resolved in 90% (P=0.0059) and esophagitis healed in 80% (P=0.008), likely due to gastric decompression. Mean percent total weight loss and percent excess weight loss were 35.2±6.6 and 108.0±11.14, respectively. CONCLUSIONS GBp-FDE seems to be a promising surgery for managing de novo GERD and obesity recurrence after SG, through SG pouch decompression and ileal stimuli, promoted by the antroileostomy. Further controlled studies with extended follow-up are necessary to validate these findings.
- Open Access
- 3 April 2025
- Published by S. Karger AG in Obesity Facts
- p. 1-35
TÜRKIYE CONSENSUS REPORT ON THE MULTIDISCIPLINARY OBESITY TREATMENT IN ADULTS
Obesity is the world's most dangerous and rapidly growing health problem. Treating people living with obesity is not limited to the weight loss process. They should also be followed up with a multidisciplinary approach to maintain the weight loss achieved. There is a lack of structural and functional standardization in obesity centers that undertake medical and surgical treatment. This consensus report, prepared by professional organizations for treating obesity, aims to ensure that all obesity centers can perform standard patient management using evidence-based workflow diagrams. The report covers all the steps, starting from the initial evaluation process. It describes how to make treatment decisions jointly, defines the responsibilities of obesity councils, and designates the follow-up procedures of medically or surgically treated patients. The consensus report underlines that all healthcare professionals treating obesity are complementary. No discipline can achieve absolute success in treating people with obesity on its own. It is mandatory to implement a sustainable and practical collaboration based on current scientific evidence in treating and following up individuals with obesity.
- 3 April 2025
- Published by S. Karger AG in Obesity Facts
- p. 1-35
Open AccessTÜRKIYE CONSENSUS REPORT ON THE MULTIDISCIPLINARY OBESITY TREATMENT IN ADULTS
Obesity is the world's most dangerous and rapidly growing health problem. Treating people living with obesity is not limited to the weight loss process. They should also be followed up with a multidisciplinary approach to maintain the weight loss achieved. There is a lack of structural and functional standardization in obesity centers that undertake medical and surgical treatment. This consensus report, prepared by professional organizations for treating obesity, aims to ensure that all obesity centers can perform standard patient management using evidence-based workflow diagrams. The report covers all the steps, starting from the initial evaluation process. It describes how to make treatment decisions jointly, defines the responsibilities of obesity councils, and designates the follow-up procedures of medically or surgically treated patients. The consensus report underlines that all healthcare professionals treating obesity are complementary. No discipline can achieve absolute success in treating people with obesity on its own. It is mandatory to implement a sustainable and practical collaboration based on current scientific evidence in treating and following up individuals with obesity.
- Open Access
- 28 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5106
Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
- 28 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5106
Open AccessDevelopment of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects
Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.
- Open Access
- 25 March 2024
- Published by Ordu University in Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi
- Vol. 7 (1) , 11-19
Bariyatrik Cerrahi Hastalarında Cerrahi Korku ile Sosyal Görünüş Kaygısı Arasındaki İlişkinin Belirlenmesi
Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi | Cilt: 7 Sayı: 1
- 25 March 2024
- Published by Ordu University in Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi
- Vol. 7 (1) , 11-19
Open AccessBariyatrik Cerrahi Hastalarında Cerrahi Korku ile Sosyal Görünüş Kaygısı Arasındaki İlişkinin Belirlenmesi
Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi | Cilt: 7 Sayı: 1
- Open Access
- 30 June 2023
- Published by Spor Bilimleri Arastirmalari Dergisi in Spor Bilimleri Araştırmaları Dergisi
- Vol. 8 (2) , 264-278
Effect of Rapid Body Weight Loss on Balance and Functional Mobility in Obese Individuals after Laparoscopic Adjustable Gastric Banding Operation
The purpose of this study was to evaluate the effect of rapid weight loss on static balance and functional mobility among excessively obese patients undergoing Laparoscopic Adjustable Gastric Banding (LAGB) surgery. Subjects (8 females; BMI >35 kg/m2) underwent baseline measurements before LAGB surgery, followed by subsequent evaluations at 6 weeks, 12 weeks, and 24 weeks during the follow-up appointments. During each evaluation, various assessments were conducted, including measurements of anthropometry such as body weight, height, hip and waist circumference, as well as functional tests for static balance, 10-meter walk, and timed get-up-and-go. There were statistically significant changes in weight, BMI, waist circumference, hip circumference, abdominal circumference, waist-hip ratio, static sway eyes open, timed up-and-go, 10-meter walk, and steps in 10-meter walk test values (p<0.001) between the baseline and the postoperative measurements. However static sway values under eyes closed condition were not statistically significant. In the 24-week follow-up, the weight loss, reduction in abdominal circumference, increase in walking speed against time and step count, and recovery in functional movements were shown to persist. Also, reduction in static balance surface oscillation confirmed the improvement of balance control.
- 30 June 2023
- Published by Spor Bilimleri Arastirmalari Dergisi in Spor Bilimleri Araştırmaları Dergisi
- Vol. 8 (2) , 264-278
Open AccessEffect of Rapid Body Weight Loss on Balance and Functional Mobility in Obese Individuals after Laparoscopic Adjustable Gastric Banding Operation
The purpose of this study was to evaluate the effect of rapid weight loss on static balance and functional mobility among excessively obese patients undergoing Laparoscopic Adjustable Gastric Banding (LAGB) surgery. Subjects (8 females; BMI >35 kg/m2) underwent baseline measurements before LAGB surgery, followed by subsequent evaluations at 6 weeks, 12 weeks, and 24 weeks during the follow-up appointments. During each evaluation, various assessments were conducted, including measurements of anthropometry such as body weight, height, hip and waist circumference, as well as functional tests for static balance, 10-meter walk, and timed get-up-and-go. There were statistically significant changes in weight, BMI, waist circumference, hip circumference, abdominal circumference, waist-hip ratio, static sway eyes open, timed up-and-go, 10-meter walk, and steps in 10-meter walk test values (p<0.001) between the baseline and the postoperative measurements. However static sway values under eyes closed condition were not statistically significant. In the 24-week follow-up, the weight loss, reduction in abdominal circumference, increase in walking speed against time and step count, and recovery in functional movements were shown to persist. Also, reduction in static balance surface oscillation confirmed the improvement of balance control.
- 1 December 2022
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 17 (4) , 225-236
Longitudinal Outcomes Through 4 Years After Sleeve Gastrectomy with Transit Bipartition
Background: Sleeve gastrectomy with transit bipartition (SG-TB) is a newer sleeve gastrectomy (SG) modification that has been reported almost exclusively over the short term. This study evaluated post SG-TB changes in weight, type 2 diabetes (T2D), and nutritional parameters through 48 months. Methods: In a single-center retrospective analysis, patients with obesity and T2D underwent SG-TB. Primary outcomes were as follows: body mass index (BMI), excess BMI loss (EBMIL), total weight loss (TWL), and glycosylated hemoglobin (A1C). Mean and median changes were assessed at 6, 12, 24, 36, and 48 months using parametric and nonparametric repeated-measures analysis of variance. Results: Between 2015 and 2019, 669 patients (mean BMI 35.7 ± 4.6 kg/m2 [30.0–57.8]) underwent SG-TB (mean age 52.2 ± 9.2 years, T2D duration 12.6 ± 6.2 years, A1C 9.7% ± 1.5%). At 48 months, 44 patients were available for analysis: Mean EBMIL was 79.4% ± 25.0% (95% confidence interval 71.8–87.0), and TWL 21.0% ± 5.9% (19.2–22.8), corresponding to a mean BMI change of 7.5 ± 2.8 kg/m2 (6.6–8.4) (p < 0.001). Complete T2D remission was achieved by 38/44 (86.4%). Significant increases occurred in the proportion of patients in the normal nutritional reference ranges. Overall complications were 10.2% with no mortality. Conclusion: Over 48 months, patients with obesity and T2D who underwent SG-TB experienced durable weight loss, T2D resolution, and nutritional stability.
- 1 December 2022
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 17 (4) , 225-236
Longitudinal Outcomes Through 4 Years After Sleeve Gastrectomy with Transit Bipartition
Background: Sleeve gastrectomy with transit bipartition (SG-TB) is a newer sleeve gastrectomy (SG) modification that has been reported almost exclusively over the short term. This study evaluated post SG-TB changes in weight, type 2 diabetes (T2D), and nutritional parameters through 48 months. Methods: In a single-center retrospective analysis, patients with obesity and T2D underwent SG-TB. Primary outcomes were as follows: body mass index (BMI), excess BMI loss (EBMIL), total weight loss (TWL), and glycosylated hemoglobin (A1C). Mean and median changes were assessed at 6, 12, 24, 36, and 48 months using parametric and nonparametric repeated-measures analysis of variance. Results: Between 2015 and 2019, 669 patients (mean BMI 35.7 ± 4.6 kg/m2 [30.0–57.8]) underwent SG-TB (mean age 52.2 ± 9.2 years, T2D duration 12.6 ± 6.2 years, A1C 9.7% ± 1.5%). At 48 months, 44 patients were available for analysis: Mean EBMIL was 79.4% ± 25.0% (95% confidence interval 71.8–87.0), and TWL 21.0% ± 5.9% (19.2–22.8), corresponding to a mean BMI change of 7.5 ± 2.8 kg/m2 (6.6–8.4) (p < 0.001). Complete T2D remission was achieved by 38/44 (86.4%). Significant increases occurred in the proportion of patients in the normal nutritional reference ranges. Overall complications were 10.2% with no mortality. Conclusion: Over 48 months, patients with obesity and T2D who underwent SG-TB experienced durable weight loss, T2D resolution, and nutritional stability.